Biologics Overshadow Small Molecules In US FDA’s 2023 Novel Approvals

 
• By Bridget Silverman
  
teamwork
Biologics dominated the products entering the FDA's expedited approval programs in 2023. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews